metaproterenol has been researched along with Body Weight in 6 studies
Metaproterenol: A beta-2 adrenergic agonist used in the treatment of ASTHMA and BRONCHIAL SPASM.
orciprenaline : A racemate composed of equimolar amounts of (R)- and (S)-orciprenaline. Used (as its sulfate salt) to relax the airway muscles and improve breathing for patients suffering from asthma or bronchitis.
5-[1-hydroxy-2-(isopropanylamino)ethyl]benzene-1,3-diol : A member of the class of resorcinols bearing an additional 1-hydroxy-2-(isopropanylamino)ethyl substituent at position 5 of resorcinol itself.
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dostanic, S | 1 |
| Servant, N | 1 |
| Wang, C | 1 |
| Chalifour, LE | 1 |
| Pascual, M | 1 |
| Del Barrio, AS | 2 |
| Portillo, MP | 2 |
| Martinez, JA | 3 |
| Larralde, J | 3 |
| Rguez-Mariscal, M | 1 |
| Günther, W | 1 |
| Kamburoff, PL | 1 |
| Dücker, R | 1 |
| Fischer, WM | 1 |
| Thomsen, K | 1 |
| Schröder, H | 1 |
1 trial available for metaproterenol and Body Weight
| Article | Year |
|---|---|
[Analysis of the maternal and fetal heart frequency after administration of direct and indirect sympathomimetic agents].
Topics: Blood Pressure; Body Height; Body Weight; Clinical Trials as Topic; Computers; Electrocardiography; | 1972 |
5 other studies available for metaproterenol and Body Weight
| Article | Year |
|---|---|
Chronic beta-adrenoreceptor stimulation in vivo decreased Bcl-2 and increased Bax expression but did not activate apoptotic pathways in mouse heart.
Topics: Adrenergic beta-Agonists; Animals; Apoptosis; bcl-2-Associated X Protein; Body Weight; Cell Survival | 2004 |
Tissue protein turnover in animals treated with the mixed beta-agonist metaproterenol: influence of dose, route and pattern of administration.
Topics: Administration, Oral; Analysis of Variance; Animals; Body Weight; Carboxypeptidases; Cathepsin A; Ca | 1993 |
The influence of oral and subcutaneous administration of a mixed beta-adrenergic agonist on tissue and cell growth.
Topics: Administration, Oral; Adrenergic beta-Agonists; Animals; Body Weight; Carboxypeptidases; Cathepsin A | 1992 |
Repartitioning effect of a mixed beta-agonist on body composition.
Topics: Adrenergic beta-Agonists; Animals; Blood Glucose; Body Composition; Body Weight; Carboxypeptidases; | 1990 |
The bronchodilator effect of a new anticholinergic drug, Sch 1000.
Topics: Administration, Intranasal; Adult; Aged; Airway Obstruction; Airway Resistance; Blood Pressure; Body | 1974 |